Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

232 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
Nio Y, Tobe T. Nio Y, et al. Nihon Geka Gakkai Zasshi. 1989 Sep;90(9):1436-8. Nihon Geka Gakkai Zasshi. 1989. PMID: 2586435 Clinical Trial. Japanese.
A self-expandable metallic stent in combination with cholangioscopic microwave coagulation therapy and chemotherapy with oral TS-1 against obstructive jaundice due to recurrent gastric cancer: a case report of successful treatment.
Nio Y, Itakura M, Koike M, Omori H, Hashimoto K, Yano S, Higami T. Nio Y, et al. Anticancer Res. 2003 Mar-Apr;23(2C):1795-801. Anticancer Res. 2003. PMID: 12820461
Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
Iguchi C, Nio Y, Itakura M. Iguchi C, et al. Among authors: nio y. J Surg Oncol. 2003 Jun;83(2):85-93. doi: 10.1002/jso.10243. J Surg Oncol. 2003. PMID: 12772201
Implication of HER-2/neu overexpression for the efficacy of oral fluoropyrimidine-based adjuvant chemotherapy in the patients with estrogen receptor negative breast cancer after surgery.
Nio Y, Itakura M, Omori H, Koike M, Hashimoto K, Yano S, Toga T, Higami T. Nio Y, et al. Anticancer Res. 2003 Jan-Feb;23(1B):745-53. Anticancer Res. 2003. PMID: 12680178
Problems in the N-classification of the new 1997 UICC TNM stage classification for gastric cancer: an analysis of over 10 years' outcome of Japanese patients.
Nio Y, Yamasawa K, Yamaguchi K, Itakura M, Omori H, Koike M, Kitamura Y, Tsuji M, Endo S, Ogo Y, Yano S, Sumi S. Nio Y, et al. Anticancer Res. 2003 Jan-Feb;23(1B):697-705. Anticancer Res. 2003. PMID: 12680170
Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreas.
Nio Y, Omori H, Toga T, Hashimoto K, Itakura M, Koike M, Yano S, Higami T. Nio Y, et al. Anticancer Drugs. 2003 Apr;14(4):313-9. doi: 10.1097/00001813-200304000-00009. Anticancer Drugs. 2003. PMID: 12679736
p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
Dong M, Nio Y, Yamasawa K, Toga T, Yue L, Harada T. Dong M, et al. Among authors: nio y. J Surg Oncol. 2003 Feb;82(2):111-20. doi: 10.1002/jso.10186. J Surg Oncol. 2003. PMID: 12561067
[A case of primary mucosa-associated lymphoid tissue (MALT) lymphoma of the cecum].
Tsuji M, Yano S, Takamura M, Sumi S, Nio Y, Higami T, Maruyama R, Nishikawa M. Tsuji M, et al. Among authors: nio y. Nihon Shokakibyo Gakkai Zasshi. 2002 Sep;99(9):1079-84. Nihon Shokakibyo Gakkai Zasshi. 2002. PMID: 12355896 Review. Japanese. No abstract available.
A fractal dimension analysis: a new method for evaluating the response of anticancer therapy.
Omori H, Nio Y, Yano S, Itakura M, Koike M, Toga T, Matsuura S. Omori H, et al. Among authors: nio y. Anticancer Res. 2002 Jul-Aug;22(4):2347-54. Anticancer Res. 2002. PMID: 12174925
Oral UFT (uracil plus futrafur) for neoadjuvant chemotherapy of gastric cancer.
Nio Y, Iguchi C, Yamasawa K, Itakura M, Omori H, Hashimoto K, Yano S, Sumi S, Tamura K. Nio Y, et al. Gastric Cancer. 1999 May;2(1):64-73. doi: 10.1007/s101200050023. Gastric Cancer. 1999. PMID: 11957073
232 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback